Johnson & Johnson has agreed to pay $5.5bn to resolve nearly 70,000 US lawsuits claiming its talc-based baby powder is tied to ovarian cancer, according to Al Jazeera.
Key facts
- Johnson & Johnson has agreed to pay $5.5bn in a proposed settlement.
- The deal covers nearly 70,000 US lawsuits.
- Claims allege a link between talc-based baby powder and ovarian cancer.
- The settlement was reported by Al Jazeera on 28 July 2026.
Johnson & Johnson has agreed to pay $5.5bn to settle nearly 70,000 US lawsuits alleging that its talc-based baby powder is linked to ovarian cancer, according to Al Jazeera.
The proposed settlement addresses one of the largest bodies of product-liability litigation the company has faced, with tens of thousands of plaintiffs pursuing claims over the health effects of its baby powder.
The lawsuits center on allegations tying talc, a key ingredient in the product, to ovarian cancer among users. The reported figure of nearly 70,000 lawsuits reflects the scale of the legal challenge confronting the company.
At $5.5bn, the payout represents a significant financial commitment aimed at resolving the outstanding claims. The details available in the reporting focus on the settlement amount and the number of lawsuits it is intended to cover.
The development, reported by Al Jazeera, marks a notable step in the long-running dispute between the company and consumers who have brought claims over its talc-based products.
Why it matters
The proposed $5.5bn settlement is one of the largest of its kind, potentially resolving legal claims from tens of thousands of people. It underscores the financial and reputational stakes for major consumer-products companies facing mass litigation over product safety.
Frequently asked questions
How much has Johnson & Johnson agreed to pay?
According to Al Jazeera, Johnson & Johnson has agreed to pay $5.5bn.
How many lawsuits does the settlement cover?
The settlement is intended to cover nearly 70,000 US lawsuits, according to Al Jazeera.
What do the lawsuits claim?
The lawsuits allege a link between the company's talc-based baby powder and ovarian cancer.